Page last updated: 2024-08-26

cyproterone acetate, ethinyl estradiol drug combination and Thrombosis

cyproterone acetate, ethinyl estradiol drug combination has been researched along with Thrombosis in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's1 (12.50)18.2507
2000's1 (12.50)29.6817
2010's5 (62.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asiimwe, A; Bezemer, ID; Herings, RMC; Penning-van Beest, FJA; Smits, E1
Arie, S1
Kant, AC; van Hunsel, FP; van Puijenbroek, EP1
Rosendaal, FR1
Kant, A; van Hunsel, F; van Puijenbroek, E1
Akcay, A; Bavbek, N; Gumus, II; Karakurt, F; Kargili, A; Koca, C; Kosar, A; Ozbek, M; Selcoki, Y1
Beaucaire, G; Beuscart, C; Brion, M; Leroy, O; Senneville, E; Tillie, I; Visticot, F1
Abbate, R; Bruni, V; Bucciantini, S; Costanzo, G; Costanzo, M; Pinto, S; Rosati, D; Verni, A1

Other Studies

8 other study(ies) available for cyproterone acetate, ethinyl estradiol drug combination and Thrombosis

ArticleYear
Thrombotic risk minimization for Diane-35 and generics.
    Pharmacoepidemiology and drug safety, 2017, Volume: 26, Issue:11

    Topics: Acne Vulgaris; Adolescent; Adult; Aged; Androgen Antagonists; Cohort Studies; Cyproterone Acetate; Databases, Factual; Drug Combinations; Drug Utilization; Drugs, Generic; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Menstruation Disturbances; Middle Aged; Netherlands; Retrospective Studies; Risk Reduction Behavior; Thrombosis; Young Adult

2017
European Commission orders France to lift ban on acne pill.
    BMJ (Clinical research ed.), 2013, Aug-05, Volume: 347

    Topics: Acne Vulgaris; Androgen Antagonists; Contraceptives, Oral; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Labeling; Ethinyl Estradiol; European Union; Female; France; Humans; Pulmonary Embolism; Safety-Based Drug Withdrawals; Thrombosis

2013
[Thrombosis and embolism during Diane-35 use: analysis of reports made to the Netherlands Pharmacovigilance Centre Lareb].
    Nederlands tijdschrift voor geneeskunde, 2014, Volume: 158

    Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Embolism; Ethinyl Estradiol; Female; Humans; Male; Netherlands; Pharmacovigilance; Risk Factors; Thrombosis

2014
[Pill matters: targeted research into side effects necessary].
    Nederlands tijdschrift voor geneeskunde, 2014, Volume: 158

    Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Embolism; Ethinyl Estradiol; Female; Humans; Male; Pharmacovigilance; Thrombosis

2014
Reflections after the Diane affair.
    Journal of thrombosis and haemostasis : JTH, 2014, Volume: 12, Issue:9

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Cyproterone Acetate; Drug Combinations; Drug Industry; Ethinyl Estradiol; Female; France; Humans; Pharmacovigilance; Thrombosis

2014
Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2008, Volume: 24, Issue:9

    Topics: Adult; Antigens; Carboxypeptidase B2; Cardiovascular Diseases; Case-Control Studies; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Models, Biological; Polycystic Ovary Syndrome; Risk Factors; Thrombosis; Up-Regulation; Young Adult

2008
Deep venous thrombosis and antibodies to cyproterone acetate.
    Lancet (London, England), 1990, Aug-25, Volume: 336, Issue:8713

    Topics: Adult; Androgen Antagonists; Antibodies; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Iliac Vein; Thrombosis

1990
[Effects of an anti-androgen combination preparation on the hemostatic system].
    Fortschritte der Medizin, 1987, Jan-30, Volume: 105, Issue:3

    Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Risk; Thrombosis

1987